John Onopchenko

John Onopchenko is a co-founder of Synergy Life Science Partners. Prior to co-founding Synergy, John was Vice President and lead medical device investor with Johnson & Johnson venture capital subsidiary, Johnson & Johnson Development Corporation. Additionally, John served on the Management Committee of JJDC. His portfolio company realizations include: Epicor, Novacept, Digirad (NASDAQ: DRAD), Genyx, Nuvasive (NASDAQ: NUVA), Vascular Control Systems, Vivant Medical and Volcano Corporation (NASDAQ: VOLC).